Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Du

Showing results (301-310 of 309) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 309 results.
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
Hemasphere|September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM studyCorentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.
Plos Medicine|December 28, 2016
Mutational Profile of Metastatic Breast Cancers: A Retrospective AnalysisCeline Lefebvre, Thomas Bachelot, Thomas Filleron, et al.
British Journal of Haematology|November 9, 2019
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC studyCatherine Thieblemont, Susannah Howlett, René-Olivier Casasnovas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2025
Structural and functional connectivity in tau mutation carriers: from presymptomatic to symptomatic frontotemporal dementiaArabella Bouzigues, Vincent Le Du, Matthieu Joulot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancerP A Francis, O Pagani, G F Fleming, et al.
Blood Advances|July 8, 2022
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsMarta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 31

Showing results (301-310 of 309) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 309 results.
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
Hemasphere|September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM studyCorentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.
Plos Medicine|December 28, 2016
Mutational Profile of Metastatic Breast Cancers: A Retrospective AnalysisCeline Lefebvre, Thomas Bachelot, Thomas Filleron, et al.
British Journal of Haematology|November 9, 2019
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC studyCatherine Thieblemont, Susannah Howlett, René-Olivier Casasnovas, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 17, 2025
Structural and functional connectivity in tau mutation carriers: from presymptomatic to symptomatic frontotemporal dementiaArabella Bouzigues, Vincent Le Du, Matthieu Joulot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancerP A Francis, O Pagani, G F Fleming, et al.
Blood Advances|July 8, 2022
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needsMarta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, et al.
The European Respiratory Journal|May 28, 2020
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesMarina Tadolini, Luigi Ruffo Codecasa, José-María García-García, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 31